Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Provides Optima with a second manufacturing site and additional capacity
July 6, 2015
By: Kristin Brooks
Managing Editor, Contract Pharma
Optima Chemical has acquired manufacturing assets in Belle, West Virginia from The Chemours Company, a wholly owned subsidiary of DuPont. Charles Hinnant, president of Charkit Chemical Corp. and its sister companies, Optima Chemical Co. and Arran Chemical, said “The acquisition now gives Optima a second manufacturing site, gaining the additional capacity that has been needed for some time. Acquiring these assets means increased manufacturing capacities for Optima, helps facilitate Optima’s growth and further strengthens our manufacturing partnership with Chemours and DuPont.” There are two chemical units within the newly acquired facility: one with FIFRA registration, allowing Optima to manufacture and offer agriculture intermediates immediately; and another that is not currently in use, which can provide capabilities similar to those available from Optima’s plant in Douglas, Georgia. The Belle facility features Hastelloy manufacturing equipment, bulk capabilities and rail and barge service. Doug Cochran, Optima’s vice president of business development has been appointed to lead the startup integration with responsibility for this new Optima plant. Other key personnel may move from the Douglas facility to support the operation in Belle, WV. Mr. Cochran said, “The acquisition situates Optima in the Kanawha Valley, known as an important area for chemical manufacturing. We conducted a careful evaluation of facilities, workforce, infrastructure, safety and environmental culture and local and state government relationships before making the transaction. After doing so, we are confident that the facility offers a unique set of capabilities and equipment that will allow Optima to better serve existing customers and to attract new customer looking for the capabilities we are now able to offer. ”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !